The Department of Veterans Affairs (VA) Veterans Health Administration awarded a $3,981,350.00 firm fixed-price purchase order contract to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, for the provision of COVID-19 reagents. The contract, which has no set-aside designation, is for the delivery of branded COVID-19 diagnostic tests compatible with Cepheid's GeneXpert systems that can simultaneously detect SARS-CoV-2, influenza A, influenza B, and RSV. The tests will be delivered to multiple VA medical centers in the Desert Pacific Healthcare Network, including facilities in California, Arizona, and New Mexico. This award is part of the VA's efforts to support clinical testing programs serving veterans and aligns with Cepheid's history of providing diagnostic equipment, reagents, and maintenance services to the VA and other federal agencies.